We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
CYSTAGON cysteamine bitartrate (mercaptamine) 150mg capsules (USA)
Section 19A approved medicine
CYSTAGON cysteamine bitartrate (mercaptamine) 150mg capsules (USA)
Section 19A approval holder
Pro Pharmaceuticals Group Pty Ltd ABN 20 605 457 430
Phone
1300 077 674
Approved until
Status
Current
Medicines in short supply/unavailable
CYSTAGON mercaptamine (cysteamine) (as bitartrate) 150mg capsule bottle - ARTG 60452
Indication(s)
CYSTAGON is indicated for the management of nephropathic cystinosis in children and adults.
Images
